JP2005514923A5 - - Google Patents

Download PDF

Info

Publication number
JP2005514923A5
JP2005514923A5 JP2003557505A JP2003557505A JP2005514923A5 JP 2005514923 A5 JP2005514923 A5 JP 2005514923A5 JP 2003557505 A JP2003557505 A JP 2003557505A JP 2003557505 A JP2003557505 A JP 2003557505A JP 2005514923 A5 JP2005514923 A5 JP 2005514923A5
Authority
JP
Japan
Prior art keywords
nucleic acid
cap
group
tables
sequence selected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003557505A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005514923A (ja
Filing date
Publication date
Priority claimed from US10/035,832 external-priority patent/US7820447B2/en
Application filed filed Critical
Publication of JP2005514923A publication Critical patent/JP2005514923A/ja
Publication of JP2005514923A5 publication Critical patent/JP2005514923A5/ja
Pending legal-status Critical Current

Links

JP2003557505A 2001-12-26 2002-12-26 癌のための新規の組成物および方法 Pending JP2005514923A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/035,832 US7820447B2 (en) 2000-12-22 2001-12-26 Compositions and methods for cancer
PCT/US2002/041414 WO2003057146A2 (en) 2001-12-26 2002-12-26 Novel compositions and methods for cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009132602A Division JP2009195249A (ja) 2001-12-26 2009-06-01 癌のための新規の組成物および方法

Publications (2)

Publication Number Publication Date
JP2005514923A JP2005514923A (ja) 2005-05-26
JP2005514923A5 true JP2005514923A5 (enExample) 2006-02-02

Family

ID=21885043

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003557505A Pending JP2005514923A (ja) 2001-12-26 2002-12-26 癌のための新規の組成物および方法
JP2009132602A Pending JP2009195249A (ja) 2001-12-26 2009-06-01 癌のための新規の組成物および方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009132602A Pending JP2009195249A (ja) 2001-12-26 2009-06-01 癌のための新規の組成物および方法

Country Status (6)

Country Link
US (1) US7820447B2 (enExample)
EP (2) EP2034030A3 (enExample)
JP (2) JP2005514923A (enExample)
AU (1) AU2002367390A1 (enExample)
CA (1) CA2471840A1 (enExample)
WO (1) WO2003057146A2 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7700274B2 (en) * 2000-12-22 2010-04-20 Sagres Discovery, Inc. Compositions and methods in cancer associated with altered expression of KCNJ9
US20030087252A1 (en) * 2000-12-22 2003-05-08 Morris David W. Novel compositions and methods in cancer associated with altered expression of PRDM11
US20040126762A1 (en) * 2002-12-17 2004-07-01 Morris David W. Novel compositions and methods in cancer
US20060194265A1 (en) * 2001-10-23 2006-08-31 Morris David W Novel therapeutic targets in cancer
US20040081653A1 (en) 2002-08-16 2004-04-29 Raitano Arthur B. Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer
EP1871484A2 (en) * 2005-04-07 2008-01-02 Chiron Corporation Sema4d in cancer diagnosis, detection and treatment
FR2890859B1 (fr) * 2005-09-21 2012-12-21 Oreal Oligonucleotide d'arn double brin inhibant l'expression de la tyrosinase
EP1975228A1 (en) * 2007-03-28 2008-10-01 Fachhochschule Mannheim Polynucleotides for enhancing expression of a polynucleotide of interest
WO2009034661A1 (en) * 2007-09-12 2009-03-19 Toppan Printing Co., Ltd. Method for diagnosis and induction of resistance to virus
EP2227693B1 (en) * 2007-11-30 2015-08-19 Clarient Diagnostic Services, Inc. Tle3 as a marker for chemotherapy
US20110229471A1 (en) 2008-11-26 2011-09-22 Cedars-Sinai Medical Center Methods of determining responsiveness to anti-tnf alpha therapy in inflammatory bowel disease
US10519505B2 (en) 2011-04-28 2019-12-31 Harry Ostrer Genomic signatures of metastasis in prostate cancer
AU2012253525B2 (en) * 2011-05-10 2016-09-22 Brunangelo Falini Hairy cell leukemia biomarkers and methods of using same
EP3639841B1 (en) 2013-03-27 2023-09-06 Cedars-Sinai Medical Center Treating fibrosis by inhibiting tl1a
EP3022295A4 (en) 2013-07-19 2017-03-01 Cedars-Sinai Medical Center Signature of tl1a (tnfsf15) signaling pathway
JP7082945B2 (ja) 2016-03-17 2022-06-09 シーダーズ―シナイ メディカル センター Ｒｎａｓｅｔ２により炎症性腸疾患を診断する方法

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
JPS6023084B2 (ja) * 1979-07-11 1985-06-05 味の素株式会社 代用血液
US4469863A (en) * 1980-11-12 1984-09-04 Ts O Paul O P Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof
US4640835A (en) * 1981-10-30 1987-02-03 Nippon Chemiphar Company, Ltd. Plasminogen activator derivatives
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4496689A (en) * 1983-12-27 1985-01-29 Miles Laboratories, Inc. Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
US5430136A (en) * 1984-10-16 1995-07-04 Chiron Corporation Oligonucleotides having selectably cleavable and/or abasic sites
US5235033A (en) * 1985-03-15 1993-08-10 Anti-Gene Development Group Alpha-morpholino ribonucleoside derivatives and polymers thereof
US5034506A (en) * 1985-03-15 1991-07-23 Anti-Gene Development Group Uncharged morpholino-based polymers having achiral intersubunit linkages
EP0206448B1 (en) * 1985-06-19 1990-11-14 Ajinomoto Co., Inc. Hemoglobin combined with a poly(alkylene oxide)
EP0272253A4 (en) 1986-03-07 1990-02-05 Massachusetts Inst Technology METHOD FOR IMPROVING GLYCOPROTE INSTABILITY.
US4791192A (en) * 1986-06-26 1988-12-13 Takeda Chemical Industries, Ltd. Chemically modified protein with polyethyleneglycol
US5124246A (en) * 1987-10-15 1992-06-23 Chiron Corporation Nucleic acid multimers and amplified nucleic acid hybridization assays using same
US5359100A (en) * 1987-10-15 1994-10-25 Chiron Corporation Bifunctional blocked phosphoramidites useful in making nucleic acid mutimers
US5700637A (en) * 1988-05-03 1997-12-23 Isis Innovation Limited Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays
US5216141A (en) * 1988-06-06 1993-06-01 Benner Steven A Oligonucleotide analogs containing sulfur linkages
GB8823869D0 (en) * 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
CA2049028A1 (en) 1989-03-07 1990-09-08 Genentech, Inc. Covalent conjugates of lipid and oligonucleotide
US5143854A (en) * 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
WO1991004753A1 (en) 1989-10-02 1991-04-18 Cetus Corporation Conjugates of antisense oligonucleotides and therapeutic uses thereof
JPH0456210A (ja) * 1990-06-26 1992-02-24 Mitsubishi Electric Corp 電子ビーム露光装置
US5602240A (en) * 1990-07-27 1997-02-11 Ciba Geigy Ag. Backbone modified oligonucleotide analogs
US5386023A (en) * 1990-07-27 1995-01-31 Isis Pharmaceuticals Backbone modified oligonucleotide analogs and preparation thereof through reductive coupling
US5625126A (en) * 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5661016A (en) * 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
KR100272077B1 (ko) * 1990-08-29 2000-11-15 젠팜인터내셔날,인코포레이티드 이종 항체를 생산할 수 있는 전이유전자를 가진 인간이외의 동물
US5633425A (en) * 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5545806A (en) * 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5644048A (en) * 1992-01-10 1997-07-01 Isis Pharmaceuticals, Inc. Process for preparing phosphorothioate oligonucleotides
US5681697A (en) * 1993-12-08 1997-10-28 Chiron Corporation Solution phase nucleic acid sandwich assays having reduced background noise and kits therefor
US5637684A (en) * 1994-02-23 1997-06-10 Isis Pharmaceuticals, Inc. Phosphoramidate and phosphorothioamidate oligomeric compounds
US6015880A (en) 1994-03-16 2000-01-18 California Institute Of Technology Method and substrate for performing multiple sequential reactions on a matrix
US5807522A (en) 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
US5580731A (en) * 1994-08-25 1996-12-03 Chiron Corporation N-4 modified pyrimidine deoxynucleotides and oligonucleotide probes synthesized therewith
US5597909A (en) * 1994-08-25 1997-01-28 Chiron Corporation Polynucleotide reagents containing modified deoxyribose moieties, and associated methods of synthesis and use
US5681702A (en) * 1994-08-30 1997-10-28 Chiron Corporation Reduction of nonspecific hybridization by using novel base-pairing schemes
US5759776A (en) * 1995-06-05 1998-06-02 California Pacific Medical Center Targets for breast cancer diagnosis and treatment
EP1295952A3 (en) 1996-01-23 2003-07-09 The Board of Trustees of The Leland Stanford Junior University Methods for screening for transdominant effector peptides and RNA molecules
US5776683A (en) * 1996-07-11 1998-07-07 California Pacific Medical Center Methods for identifying genes amplified in cancer cells
US5928870A (en) * 1997-06-16 1999-07-27 Exact Laboratories, Inc. Methods for the detection of loss of heterozygosity
US6074825A (en) * 1997-07-31 2000-06-13 Maine Medical Center Stable encapsulated reference nucleic acid and method of making
US6153441A (en) 1998-02-17 2000-11-28 Smithkline Beecham Corporation Methods of screening for agonists and antagonists for human CCR7 receptor and CKβ-9 ligand and interaction thereof
EP1358349A2 (en) 2000-06-05 2003-11-05 Avalon Pharmaceuticals Cancer gene determination and therapeutic screening using signature gene sets
US6812339B1 (en) * 2000-09-08 2004-11-02 Applera Corporation Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
WO2002022660A2 (en) 2000-09-11 2002-03-21 Hyseq, Inc. Novel nucleic acids and polypeptides
EP1353947A2 (en) * 2000-12-08 2003-10-22 Ipsogen Gene expression profiling of primary breast carcinomas using arrays of candidate genes
US20030216558A1 (en) 2000-12-22 2003-11-20 Morris David W. Novel compositions and methods for cancer
WO2003008583A2 (en) 2001-03-02 2003-01-30 Sagres Discovery Novel compositions and methods for cancer
NL1033850C2 (nl) 2007-05-15 2008-11-18 3Force B V Brandersysteem met voorgemengde branders en vlam-overdrachtsmiddelen.
WO2013037693A2 (de) 2011-09-15 2013-03-21 Convergent Information Technologies Gmbh System und verfahren zur automatisierten erstellung von roboterprogrammen
US9505153B2 (en) 2012-02-13 2016-11-29 Radius Engineering, Inc. Reusable cartridge for injection molding

Similar Documents

Publication Publication Date Title
JP2006507794A5 (enExample)
JP2005514923A5 (enExample)
JP2005512558A5 (enExample)
CA2488404A1 (en) Genes and polypeptides relating to human colon cancers
JP6496003B2 (ja) Ｆｇｆ−１８化合物に対する応答性を予測するための遺伝子マーカー
JP2006518991A5 (enExample)
JP2007506426A5 (enExample)
JP6272860B2 (ja) 軟骨障害の予後バイオマーカー
JP2011512163A5 (enExample)
JP2005522999A5 (enExample)
Mahon et al. Is persistent adenovirus 12 infection involved in coeliac disease? A search for viral DNA using the polymerase chain reaction.
JP2006518186A5 (enExample)
JP2005537007A5 (enExample)
JP2008512984A5 (enExample)
CN105659085A (zh) 预测受试者对多激酶抑制剂的反应的基因表达标志及其使用方法
JP2002518051A5 (enExample)
RU2004117536A (ru) Новые изоформы ингибитора роста васкулярных эндотелиальных клеток
JP2005511023A5 (enExample)
JP2005531290A5 (enExample)
JP2005535289A5 (enExample)
JP2005526508A5 (enExample)
JP2006503575A5 (enExample)
JP6141275B2 (ja) 線維症感受性ｉｌ２２ｒａ２遺伝子およびその使用
JP2004535161A5 (enExample)
JP2005538692A5 (enExample)